COVID-19 and the kidney: what we think we know so far and what we don't
The novel coronavirus disease infection (COVID-19) outbreak that was declared a global
pandemic in March 2020 had led to an internationally variable but concerning incidence of …
pandemic in March 2020 had led to an internationally variable but concerning incidence of …
The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
The pandemic of coronavirus disease 2019 (CoVID-19) has been an unprecedented period.
The disease afflicts multiple organ systems, with acute kidney injury (AKI) a major …
The disease afflicts multiple organ systems, with acute kidney injury (AKI) a major …
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
J Colmenero, M Rodríguez-Perálvarez, M Salcedo… - Journal of …, 2021 - Elsevier
Background & Aims The incidence and outcomes of coronavirus disease 2019 (COVID-19)
in immunocompromised patients are a matter of debate. Methods We performed a …
in immunocompromised patients are a matter of debate. Methods We performed a …
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty …
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty …
Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European …
Background and Aims Despite concerns that liver transplant (LT) recipients may be at
increased risk of unfavorable outcomes from COVID-19 due the high prevalence of co …
increased risk of unfavorable outcomes from COVID-19 due the high prevalence of co …
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
There is an urgent need for antivirals to treat the newly emerged severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). To identify new candidates, we screen a …
syndrome coronavirus 2 (SARS-CoV-2). To identify new candidates, we screen a …
COVID-19 hospitalization in solid organ transplant recipients on immunosuppressive therapy
E Kolla, A Weill, M Zaidan, E De Martin… - JAMA Network …, 2023 - jamanetwork.com
Importance Solid organ transplant recipients are at high risk of severe infection with SARS-
CoV-2 compared with the general population. However, factors associated with COVID-19 …
CoV-2 compared with the general population. However, factors associated with COVID-19 …
Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center
M Lubetzky, MJ Aull, R Craig-Schapiro… - Nephrology Dialysis …, 2020 - academic.oup.com
Background Kidney graft recipients receiving immunosuppressive therapy may be at
heightened risk for coronavirus disease 2019 (Covid-19) and adverse outcomes. It is …
heightened risk for coronavirus disease 2019 (Covid-19) and adverse outcomes. It is …
SARS‐CoV‐2‐specific serological and functional T cell immune responses during acute and early COVID‐19 convalescence in solid organ transplant patients
A Favà, L Donadeu, N Sabé, V Pernin… - American Journal of …, 2021 - Wiley Online Library
The description of protective humoral and T cell immune responses specific against SARS‐
CoV‐2 has been reported among immunocompetent (IC) individuals developing COVID‐19 …
CoV‐2 has been reported among immunocompetent (IC) individuals developing COVID‐19 …
Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients
BA Sarrell, K Bloch, A El Chediak… - Transplant Infectious …, 2022 - Wiley Online Library
Solid organ transplant (SOT) recipients are at high risk for severe coronavirus disease 2019
(COVID‐19). Studies suggest that early intervention with monoclonal antibody (MAB) …
(COVID‐19). Studies suggest that early intervention with monoclonal antibody (MAB) …